The Gross Margin of Adaptimmune Therapeutics PLC (ADAP) is 99.96%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 99.96% |